Blood-Stage
Showing 1 - 25 of >10,000
Plasmodium Vivax Infection Trial in Bangkok (An inoculum of malaria parasitised red blood cells with whole dose blood-stage
Recruiting
- Plasmodium Vivax Infection
- An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum
- +3 more
-
Bangkok, ThailandFaculty of Tropical Medicine
Jun 21, 2022
Malaria,Falciparum Trial in Sigle (Rabies vaccine, RH5.1 10µg adjuvated with 50µg Matrix-M, RH5.2 5µg adjuvated with 50µg
Recruiting
- Malaria,Falciparum
- Rabies vaccine
- +2 more
-
Sigle, Boulkiemdé Province, Burkina FasoInstitut de Recherche en Sciences de la Santé
Apr 3, 2023
Malaria Trial run by the NIAID (HMPBS02-Pv)
Active, not recruiting
- Malaria
- HMPBS02-Pv
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 5, 2022
Malaria,Falciparum, Malaria, Malaria Recrudescence Trial in Brisbane (Pyronaridine, P. falciparum IBSM infection)
Completed
- Malaria,Falciparum
- +5 more
- Pyronaridine
- P. falciparum IBSM infection
-
Brisbane, Queensland, Australia
- +1 more
Nov 3, 2022
Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome Trial in Brisbane (MMV367, P. falciparum IBSM
Recruiting
- Infections
- +11 more
- MMV367
- P. falciparum IBSM infection
-
Brisbane, Queensland, Australia
- +1 more
Jul 30, 2023
Malaria, Plasmodium Falciparum Trial in Bagamoyo (P. falciparum infected erythrocytes)
Not yet recruiting
- Malaria
- Plasmodium Falciparum
- P. falciparum infected erythrocytes
-
Bagamoyo, TanzaniaIfakara Health Institute
May 26, 2022
Malaria, Falciparum Trial in Oxford (Matrix M with R78C and/or RH5.1)
Not yet recruiting
- Malaria, Falciparum
- Matrix M with R78C and/or RH5.1
-
Oxford, United KingdomCCVTM, University of Oxford, Churchill Hospital
May 26, 2022
Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)
Not yet recruiting
- Malaria, Plasmodium Falciparum
- Matrix-M with RH5.2 VLP and/or R21
- (no location specified)
Oct 21, 2022
Malaria, Vivax Trial in Oxford (PvDBPII/Matrix-M1)
Recruiting
- Malaria, Vivax
- PvDBPII/Matrix-M1
-
Oxford, United KingdomCCVTM, University of Oxford, Churchill Hospital
Feb 8, 2022
Plasmodium Vivax Infection, Malaria Vaccine Trial in Bangkok (Malaria Vaccine, HBV vaccine)
Not yet recruiting
- Plasmodium Vivax Infection
- Malaria Vaccine
- Malaria Vaccine
- HBV vaccine
-
Bangkok, ThailandFaculty of Tropical Medicine
Jan 16, 2023
LIver, Biliary tRAct and pancReatic Cancers
Recruiting
- Liver Cancer
- +2 more
- Blood drawing
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, Zhejiang University School of Me
Nov 14, 2023
Resistant Arterial Hypertension Trial in Ryazan (Blood samples will be taken for pharmacokinetics and pharmacogenetics)
Recruiting
- Resistant Arterial Hypertension
- Blood samples will be taken for pharmacokinetics and pharmacogenetics
-
Ryazan, Russian FederationRyzan State Medical University
Jun 1, 2023
Malaria,Falciparum Trial in Bagamoyo (RH5.1/Matrix-M)
Enrolling by invitation
- Malaria,Falciparum
- RH5.1/Matrix-M
-
Bagamoyo, TanzaniaIfakara Health Institute Clinical Trial Facility
Oct 21, 2022
Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial (Liquid Biopsy)
Not yet recruiting
- Hepatocellular Carcinoma
- +4 more
- Liquid Biopsy
- (no location specified)
Apr 18, 2023
GAMAD for Early-stage HCC Based on Circulating Tumor DNA
Not yet recruiting
- Hepatocellular Carcinoma
- GAMAD
- (no location specified)
Nov 22, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Active, not recruiting
- Stage III Cutaneous Melanoma AJCC v7
- +4 more
- Cryosurgery
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jan 3, 2023
Cancer Colorectal Trial (a multi-locus blood-based assay)
Not yet recruiting
- Cancer Colorectal
- a multi-locus blood-based assay
- (no location specified)
Sep 7, 2022
Fibrinogen and Intraoperative Bleeding in Liver Transplant
Completed
- End Stage Liver DIsease
- Liver Transplant; Complications
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Nov 24, 2022
Chronic Kidney Disease stage3 Trial (Blood samples)
Not yet recruiting
- Chronic Kidney Disease stage3
- Blood samples
- (no location specified)
Aug 30, 2023
Alcohol Use, Alcohol Drinking, Drinking Behavior Trial in Boston (Alcohol-related mobile health technologies, Motivational
Recruiting
- Alcohol Use
- +2 more
- Alcohol-related mobile health technologies
- Motivational interview and psychoeducation on blood/breath alcohol concentration
-
Boston, MassachusettsEDGE Lab
Nov 6, 2023
Blood Samples in Patients With Non-small Cell Lung Cancer
Recruiting
- Stage III Non-Small Cell Lung Cancer AJCC v7
- +3 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 18, 2022
Malaria,Falciparum, Parasitemia, Protozoan Infections Trial in Antwerpen (Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet,
Completed
- Malaria,Falciparum
- +3 more
- Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
- PfSPZ-DVI Challenge
-
Antwerpen, BelgiumSGS Belgium NV Clinical Pharmacology Unit
Sep 3, 2021
Menopause, Elevated Blood Pressure, Hypertension Trial in Fort Collins (Blueberry Powder, Placebo Powder)
Completed
- Menopause
- +3 more
- Blueberry Powder
- Placebo Powder
-
Fort Collins, ColoradoDepartment of Food Science and Human Nutrition, Colorado State U
Sep 9, 2022
End-Stage Renal Disease
Completed
- Hemodialysis
- Pulsevelocity
-
Tehran, Iran, Islamic Republic ofSBMU
Jan 27, 2022